132 related articles for article (PubMed ID: 6230929)
1. Randomized trial of chlorozotocin, neocarzinostatin, or methyl-CCNU in patients with malignant melanoma.
Von Hoff DD; Amato DA; Kaufman JH; Falkson G; Cunningham TJ
Am J Clin Oncol; 1984 Apr; 7(2):135-9. PubMed ID: 6230929
[TBL] [Abstract][Full Text] [Related]
2. [Immuno-chemotherapy in patients with disseminated metastasizing stage III melanoma. Randomized study with methyl-CCNU versus C. parvum plus methyl-CCNU].
Kokoschka EM; Luger T; Micksche M
Onkologie; 1978 Jun; 1(3):98-103. PubMed ID: 362293
[TBL] [Abstract][Full Text] [Related]
3. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
Zeller WJ; Eisenbrand G; Fiebig HH
J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanoma.
Ahmann DL; Frytak S; Kvols LK; Hahn RG; Edmonson JH; Bisel HF; Creagan ET
Cancer Treat Rep; 1980; 64(4-5):721-3. PubMed ID: 6448689
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
Einhorn LH; Furnas B
Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.
Osieka R; Glatte P; Pannenbäcker R; Schmidt CG
Cancer Chemother Pharmacol; 1983; 11(3):147-52. PubMed ID: 6227420
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of melanoma.
Luce JK
Semin Oncol; 1975 Jun; 2(2):179-85. PubMed ID: 1234375
[No Abstract] [Full Text] [Related]
8. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma.
Cohen MH; Schoenfeld D; Wolter J
Cancer Treat Rep; 1980 Jan; 64(1):151-3. PubMed ID: 6991102
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
Knost JA; Reynolds V; Greco FA; Oldham RK
J Surg Oncol; 1982 Mar; 19(3):165-70. PubMed ID: 7040820
[No Abstract] [Full Text] [Related]
10. Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group report.
Van Amburg AL; Presant CA; Burns D
Cancer Treat Rep; 1982 Jun; 66(6):1431-3. PubMed ID: 6211234
[TBL] [Abstract][Full Text] [Related]
11. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma.
Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; Eagan RT; O'Connell MJ; Frytak S
Clin Pharmacol Ther; 1976 Jun; 19(6):821-4. PubMed ID: 773589
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
[TBL] [Abstract][Full Text] [Related]
13. Cure rates and tumor resistance in cured mice after nitrosourea treatment of EMT6 ascites tumors.
Feola JM; Maruyama Y
Oncology; 1986; 43(6):372-7. PubMed ID: 2949185
[TBL] [Abstract][Full Text] [Related]
14. Results with methyl-CCNU and DTIC in metastatic melanoma.
Costanza ME; Nathanson L; Schoenfeld D; Wolter J; Colsky J; Regelson W; Cunningham T; Sedransk N
Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of chlorozotocin in malignant melanoma, breast cancer, and other solid tumors.
Silver BA; Barlock AL; Lippman ME; Anderson T; Fisher RI
Cancer Treat Rep; 1982 May; 66(5):1229-30. PubMed ID: 6211231
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
Sordillo PP; Magill GB
Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF
Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
[No Abstract] [Full Text] [Related]
18. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
[No Abstract] [Full Text] [Related]
19. Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy.
Didolkar MS; Baffi RR; Catane R; Kaufman J; Holyoke ED
Cancer Treat Rep; 1977 Dec; 61(9):1738-9. PubMed ID: 597824
[No Abstract] [Full Text] [Related]
20. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.
Sava G; Giraldi T
Cancer Chemother Pharmacol; 1983; 10(3):167-9. PubMed ID: 6222844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
